MedPath

LEO Pharma A/S

LEO Pharma A/S logo
🇩🇰Denmark
Ownership
Subsidiary
Established
1908-01-01
Employees
5K
Market Cap
-
Website
http://www.leo-pharma.com

Clinical Trials

4

Active:2
Completed:1

Trial Phases

2 Phases

Phase 2:1
Phase 4:1

Drug Approvals

59

CIMA_AEMPS:31
NMPA:19
EMA:4
+2 more agencies

Drug Approvals

Calcipotriol and Betamethasone Dipropionate Gel

Product Name
Xamiol
Approval Number
国药准字HJ20150687
Approval Date
Nov 20, 2024
NMPA

Calcipotriol and Betamethasone Dipropionate Gel

Product Name
Xamiol
Approval Number
国药准字HJ20150372
Approval Date
Nov 20, 2024
NMPA

Fusidic Acid Cream

Product Name
立思丁
Approval Number
国药准字HJ20130928
Approval Date
Aug 1, 2023
NMPA

Fusidic Acid Cream

Product Name
立思丁
Approval Number
国药准字HJ20130921
Approval Date
Aug 1, 2023
NMPA

Calcipotriol and Betamethasone Ointment

Product Name
得肤宝
Approval Number
国药准字HJ20160204
Approval Date
Jul 4, 2023
NMPA

Tacrolimus Ointment

Product Name
普特彼
Approval Number
国药准字HJ20181015
Approval Date
Mar 12, 2021
NMPA

Tacrolimus Ointment

Product Name
普特彼
Approval Number
国药准字HJ20181016
Approval Date
Mar 12, 2021
NMPA

Calcipotriol Ointment

Product Name
达力士
Approval Number
国药准字HJ20160069
Approval Date
Jan 5, 2021
NMPA

Calcipotriol Ointment

Product Name
达力士
Approval Number
国药准字HJ20160070
Approval Date
Jan 5, 2021
NMPA

Calcipotriol Scalp Solution

Product Name
达力士
Approval Number
国药准字HJ20150664
Approval Date
Sep 4, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

1 (25.0%)
Phase 2
1 (25.0%)
phase_2_3
1 (25.0%)
Phase 4
1 (25.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.